Stephen Salton, MD, PhD
img_Stephen Salton
PROFESSOR | Neuroscience
PROFESSOR | Geriatrics and Palliative Medicine
Research Topics
Adipose, Aging, Apoptosis/Cell Death, Axon Guidance, Brain, Cell Adhesion, Chromogranins and Secretogranins, Cognitive Neuroscience, Cytoskeleton, Depression, Diabetes, Growth Cone, Growth Factors and Receptors, Hormones, Memory, Neuropeptides, Neurotrophins, Obesity, Protein Phosphatases, Protein Trafficking & Sorting, Signal Transduction, Synapses
Multi-Disciplinary Training Area
Neuroscience [NEU]
Research
Specific Clinical/Research Interests:  Molecular Neuroscience; Neurotrophin Signaling; Neuropeptides; Neural Cell Adhesion Molecules; Obesity; Diabetes; Depression; Major Depressive Disorder; Alzheimer's Disease.

Summary of Research Studies: Our research is focused on understanding the mechanisms by which neurotrophic growth factors, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), regulate nervous system development and function. BDNF and NGF have been implicated in the pathophysiology of neurodegenerative disease, neuropsychiatric illness, CNS injury, and obesity. The contributions made by specific neurotrophin-regulated gene products to depression, memory, and energy balance, are being being examined using novel knockout, transgenic, and knockin mouse models. The lab has identified VGF, a secreted neuronal and neuroendocrine peptide precursor, and the cell adhesion molecule (CAM) L1 or NILE, as important gene products that are induced by neurotrophins including NGF and BDNF during neural differentiation and CNS/PNS development. Cultured neurons, neural and endocrine cell lines, hippocampal slices, and mouse models are all utilized to study effects of these proteins on synaptic plasticity, neurogenesis, axonal outgrowth, and axonal pathfinding. We are currently determining the signaling pathways, networks, and functional roles that these neurotrophin-regulated molecules play in clinically relevant diseases, including in major depressive disorder, neuropathic pain, obesity, and Alzheimer's disease.

Visit Dr. Stephen Salton's Lab for more information.

BA, University of Pennsylvania

Fellowship, Columbia Presbyterian and Mount Sinai School of Medicine

Internship and Residency, Bellevue and NYU School of Medicine

MD, New York University

PhD, New York University

2008

NARSAD van Ameringen Investigator

2006

NARSAD Independent Investigator

1994

Irma T. Hirschl Career Scientist

1991

Pew Scholar in the Biomedical Sciences

1989

Pfizer Scholar

1986

Pfizer Postdoctoral Fellow

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Salton has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.